Preliminary Clinical Validation of a Differential Correction Method for Improving Measurement Accuracy in Noninvasive Measurement of Blood Glucose Using Near-Infrared Spectroscopy.
One of the main challenges in the noninvasive sensing of blood glucose by near-infrared (NIR) spectroscopy is the background variations from light source drift, sweating, and temperature change at the human-machine interface. In this paper, a differential correction method based on the spectra from the floating-reference position and measuring position is proposed to eliminate these spectral variations from background interferences. Its effectiveness was validated by in vitro and in vivo experiments in which the diffuse reflectance of intralipid solutions and human skin was collected at the source distances of 0.6 mm and 2 mm by the custom-built system with six super-luminescent emitting diodes (SLEDs) light source. The results showed that, for the in vitro experiments of intralipid solutions, the coefficients of variations of diffuse reflectance decreased by 20.5% under all the six wavelengths after differential correction. For the in vivo experiments of oral glucose tolerance tests (OGTTs), partial least squares (PLS) regression models between glucose concentrations and the diffuse reflectance from palm skin were built, and the root mean square error of cross validation (RMSECV) decreased by 38.0% on average after the differential correction. Further, the spectra of the oral water tolerance tests (OWTTs) were collected for correlation with glucose concentration in OGTTs, and their correlation coefficients (R) decreased by 35.0% on average after the differential correction. Therefore, this differential correction method based on the spectra from the floating-reference position and measuring position can weaken the influence of background variations on the NIR spectroscopy and has promising potential in in vivo detection, especially for noninvasive blood glucose measurement.